Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Wansheng Pharmaceutical is a prominent Chinese pharmaceutical manufacturer and a key subsidiary of the CSPC Pharmaceutical Group. Based in Shijiazhuang, the company specializes in the research, development, and large-scale production of finished drug formulations. Its product portfolio primarily focuses on therapeutic areas such as cardiovascular diseases, cerebrovascular conditions, and anti-infectives. As a core production base for its parent group, the company operates under strict GMP standards to supply both domestic and international markets. One of its most notable products is the widely distributed antihypertensive medication, amlodipine besylate.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hebei Wansheng Pharmaceutical.